Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Elagolix Extension Study in Endometriosis-Associated Pain
NCT02143713Phase 3Completed
- Sponsor
- AbbVie Inc.
- Start
- May 2014
- Primary completion
- Jun 2016
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of elagolix in endometriosis, sponsored by AbbVie Inc.. Started May 2014; status: completed.
02
Drugs
elagolix
03
Conditions
endometriosis
Beyond the preview
Go deeper on NCT02143713.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02143713.